Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Prospective study of cytomegalovirus seropositivity and risk of mortality from diabetes. Acta Diabetol 2014 Oct;51(5):723-9

Date

03/19/2014

Pubmed ID

24633860

DOI

10.1007/s00592-014-0573-3

Scopus ID

2-s2.0-84919466592 (requires institutional sign-in at Scopus site)   9 Citations

Abstract

Cytomegalovirus (CMV) infects 40 % of the world population and has been suggested to be associated with diabetes; however, no prospective study has ever examined diabetes mortality associated with the infection. A cohort of 14,404 non-diabetic adult participants aged 17-90 years from the Third National Health and Nutrition Examination Survey (1988-1994) was prospectively followed for mortality through 2006. CMV immunoglobulin G was measured by enzyme-linked immunosorbent assay and immunofluorescence assay. Diabetes death was assessed with death records from the National Death Index. Cox proportional hazards modeling was used to determine diabetes mortality risk associated with CMV infection, adjusting for socio-demographics, diabetes risk factors, and comorbidities. At baseline, 76.8 % of subjects were CMV seropositive, and after an average follow-up of 13.7 years, diabetes mortality rate per 10,000 person-years was 6.8 (95 % CI 5.7, 8.0). Among seropositive participants, the diabetes death rate (8.4, 95 % CI 7.0, 9.9) was more than four times the rate in seronegative ones (2.0, 95 % CI 1.1, 3.6) (P value for the difference <0.001). In the adjusted Cox proportional hazards analysis, CMV seropositivity more than doubled the risk of diabetes mortality (HR 2.06, 95 % CI 1.05, 4.06). CMV infection may thus predict future mortality from diabetes in non-diabetic people.

Author List

Mendy A, Gasana J, Vieira ER, Diallo H

Author

Janvier Gasana MD, MPH, PhD Adjunct Associate Professor in the Institute for Health and Equity department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Aged
Aged, 80 and over
Antibodies, Viral
Cytomegalovirus
Cytomegalovirus Infections
Diabetes Mellitus
Female
Humans
Male
Middle Aged
Nutrition Surveys
Prospective Studies
Young Adult